Guillaume Ploussard
Hôpital de la Croix-Rousse, Clinique Saint Jean Languedoc, Institut universitaire du cancer de Toulouse Oncopole, Groupe Hospitalier Diaconesses Croix Saint-Simon, Université Paris-Sud, GTx (United States), Lyon Genou Centre Albert Trillat, Jewish General Hospital, Karolinska Institutet, Air Liquide (France), Lymphoma Study Association
Papers
40
Total Citations
866
H-Index
17
About
Guillaume Ploussard is a prominent urological surgeon and researcher whose work sits at the intersection of robotic surgery, oncological urology, and perioperative care optimization. His research has fundamentally advanced understanding of minimally invasive surgical approaches for urological cancers, particularly bladder and prostate cancer, through rigorous multi-institutional and multinational comparative analyses. Ploussard's most cited contributions examine the adoption and outcomes of robot-assisted radical cystectomy (RARC) and prostatectomy (RARP) relative to open and laparoscopic techniques, with landmark collaborative studies drawing on thousands of patients across North America and Europe. His 2019 international collaboration on radical cystectomy trends (82 citations) and his 2018 French multicenter study on intracorporeal versus extracorporeal urinary diversion (74 citations) have become essential references in the field. Notably, he has been a driving force behind same-day discharge protocols and the integration of enhanced recovery after surgery (ERAS) with prehabilitation programs, demonstrating meaningful reductions in costs and complications. His systematic review on focal ablative therapy for localized prostate cancer (52 citations) further underscores his broad clinical scope. Collectively, his body of work—spanning robotic technique innovation, health economics, and patient recovery pathways—has significantly shaped contemporary urological surgical practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Robotic surgery in urology69 citations · 2017
- 4
- 5
- 6
- 7
- 8
- 9
- 10